메뉴 건너뛰기




Volumn 153, Issue 5, 2005, Pages 1088-1090

Clinical and immunological features of hepatitis C treatment-associated dermatitis in 36 prospective cases [15]

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PEGINTERFERON ALPHA2A; RIBAVIRIN;

EID: 27544439540     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06931.x     Document Type: Letter
Times cited : (36)

References (8)
  • 1
    • 0032547938 scopus 로고    scopus 로고
    • Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
    • Hepatitis Interventional Therapy Group
    • McHutchison JG, Gordon SC, Schiff ER et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339:1485-92.
    • (1998) N Engl J Med , vol.339 , pp. 1485-1492
    • McHutchison, J.G.1    Gordon, S.C.2    Schiff, E.R.3
  • 2
    • 0142025172 scopus 로고    scopus 로고
    • Cutaneous side-effects of treatment of chronic hepatitis C by interferon alfa and ribavirin
    • Kerl K, Negro F, Lübbe J. Cutaneous side-effects of treatment of chronic hepatitis C by interferon alfa and ribavirin. Br J Dermatol 2003; 149:656.
    • (2003) Br J Dermatol , vol.149 , pp. 656
    • Kerl, K.1    Negro, F.2    Lübbe, J.3
  • 3
    • 0032792834 scopus 로고    scopus 로고
    • High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus
    • Sookoian S, Neglia V, Castano G et al. High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus. Arch Dermatol 1999; 135:1000-1.
    • (1999) Arch Dermatol , vol.135 , pp. 1000-1001
    • Sookoian, S.1    Neglia, V.2    Castano, G.3
  • 4
    • 17944373513 scopus 로고    scopus 로고
    • Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus
    • Letter
    • Manjon-Haces J, Vazquez-Lopez F, Gomez-Diez S. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus. Acta Derm Venereol (Stockh) 2001; 81:223 (Letter).
    • (2001) Acta Derm Venereol (Stockh) , vol.81 , pp. 223
    • Manjon-Haces, J.1    Vazquez-Lopez, F.2    Gomez-Diez, S.3
  • 5
    • 0036886385 scopus 로고    scopus 로고
    • Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: A series of 20 patients
    • Dereure O, Raison-Peyron N, Larrey D et al. Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients. Br J Dermatol 2002; 147:1142-6.
    • (2002) Br J Dermatol , vol.147 , pp. 1142-1146
    • Dereure, O.1    Raison-Peyron, N.2    Larrey, D.3
  • 6
    • 0034084271 scopus 로고    scopus 로고
    • Alpha interferon-induced eczema in atopic patients infected by hepatitis C virus: 4 Case reports
    • Berger L, Descamps V, Marck Y et al. [Alpha interferon-induced eczema in atopic patients infected by hepatitis C virus: 4 case reports]. Am Dermatol Venereol 2000; 127:51-5.
    • (2000) Am Dermatol Venereol , vol.127 , pp. 51-55
    • Berger, L.1    Descamps, V.2    Marck, Y.3
  • 7
    • 0033963510 scopus 로고    scopus 로고
    • Reproducibility of the atopy patch test with whole house dust mite bodies in atopic dermatitis
    • Ingordo V, D'Andria G, Cannata AT. Reproducibility of the atopy patch test with whole house dust mite bodies in atopic dermatitis. Contact Dermatitis 2000; 42:174-5.
    • (2000) Contact Dermatitis , vol.42 , pp. 174-175
    • Ingordo, V.1    D'Andria, G.2    Cannata, A.T.3
  • 8
    • 0033816721 scopus 로고    scopus 로고
    • Combination treatment for chronic hepatitis C: What is the role of ribavirin?
    • Souvignet C, Zarski JP. Combination treatment for chronic hepatitis C: what is the role of ribavirin? Fundam Clin Pharmacol 2000; 14:321-5.
    • (2000) Fundam Clin Pharmacol , vol.14 , pp. 321-325
    • Souvignet, C.1    Zarski, J.P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.